This double-blind, randomized, placebo-controlled study will evaluate the tolerability, safety and antiviral activity of GS 9137 (also known as JTK-303), in HIV-positive patients. The drug will be administered
The double-blinded clinical study compared recombinant human hyaluronidase (rHuPH20) to a saline control in 100 healthy human volunteers. These volunteers were injected intradermally with rHuPH20 in one forearm
The company plans to begin a phase III study in recurrent respiratory papillomatosis (RRP) in the first quarter of 2006, pending review by the FDA. The study will
The company succeeded in achieving the primary endpoint of the trial to establish the safety of the drug. BrachySil (32-P BioSilicon) was found to be both safe and
The follow-up data from the Teva’s four year trial showed the drug’s efficacy compared with beta interferon therapies. Final results of a four year study using a prospectively
The drug was evaluated in a TNBS-induced ulcerative colitis mouse model, which is an animal model widely used to evaluate drug candidates for treatment of human inflammatory bowel
The multi-center study has enrolled over 600 women diagnosed with irritable bowel syndrome (IBS). This US investigation is designed to compare the safety and efficacy of PTI-901 against
The technology results in an unprecedented control over the shape, size and composition of material. The particles produced are made from bioabsorbable organic materials creating a nontoxic method
The new data show that monthly NeuroVax injections during a one-year period increased FOXP3, a gene marker recently shown to track regulatory T-cells, and improve Treg cell functional
Physicians using Mednet System’s emr4MD Electronic Medical Record (EMR) to electronically exchange prescription data via computer or tablet PC will now be able to connect with pharmacies at
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.